AGIOS PHARMACEUTICALS, INC. ($AGIO)
Filing Information
| Accession Number | 0001439222-26-000063 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 6, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
20,141
Total Value
$109,024.11
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common stock | โ | Apr 2, 2026 | Exercise/Conversion | 8,500 | $0.00 | $0.00 | 58,139 | Direct | โ | View Details | |
Chief Financial Officer | Common stock | โ | Apr 2, 2026 | Sale | 3,141 | $34.71 | $109,024.11 | 54,998 | Direct | โ | View Details | |
Chief Financial Officer | Performance share units | Derivative | Apr 2, 2026 | Exercise/Conversion | 8,500 | $0.00 | $0.00 | 8,500 | Direct | โ | View Details |